Zobrazeno 1 - 10
of 967
pro vyhledávání: '"E. A. Melnikov"'
Autor:
G. V. Adamov, O. L. Saybel, A. N. Babenko, E. S. Melnikov, A. I. Radimich, O. Yu. Kulyak, L. V. Krepkova
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 3, Pp 126-137 (2024)
Introduction. The development and registration of antiviral drugs is an urgent task. Flavonoids, in particular, luteolin-7-glycoside (cinaroside, luteolin-7-O-glycoside) demonstrate high broad-spectrum antiviral activity in vitro, and the industrial
Externí odkaz:
https://doaj.org/article/575addec5020478cb344cfad64f53309
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 2, Pp 171-180 (2024)
Introduction. The number of peptide drugs being developed and registered has increased in recent years. Therefore, modern analytical approaches and methods are required to determine these substances in biological matrices during pharmacokinetic studi
Externí odkaz:
https://doaj.org/article/ca229898dcb64eb98ed226927dc02bf9
Autor:
M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 7 (2024)
Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of mark
Externí odkaz:
https://doaj.org/article/e6737166623e4811afc3782016a90baa
Autor:
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, T. I. Batluk, N. A. Koziolova, A. I. Chesnikova, A. Y. Vaskin, D. S. Tokmin, I. G. Bakulin, O. L. Barbarash, N. U. Grigoryeva, I. V. Gubareva, N. V. Izmozherova, U. K. Kamilova, S. G. Kechedzhieva, Z. F. Kim, N. A. Koriagina, S. V. Mironova, N. P. Mitkovskaya, S. V. Nemirova, L. M. Nurieva, M. M. Petrova, E. A. Polyanskaya, A. P. Rebrov, A. V. Svarovskaya, E. A. Smirnova, A. B. Sugraliev, Y. B. Khovaeva, G. V. Shavkuta, I. I. Shaposhnik, M. Y. Alieva, A. B. Almukhanova, A. V. Aparkina, R. A. Bashkinov, L. N. Belousova, E. I. Blokhina, V. O. Bochkareva, M. V. Buianova, F. Y. Valikulova, A. D. Vende, A. S. Galyavich, V. V. Genkel, E. V. Gorbunova, E. D. Gordeychuk, E. A. Grigorenko, E. V. Grigoryeva, I. L. Davydkin, D. S. Evdokimov, A. N. Ermilova, S. B. Zhangelova, N. V. Zhdankina, E. I. Zheleznyak, N. S. Ilyanok, D. A. Kapsultanova, N. A. Karoli, E. A. Kartashova, A. S. Kuznetsova, A. T. Kumaritova, N. A. Magdeeva, S. A. Makarov, E. S. Melnikov, M. V. Novikova, I. A. Obukhova, E. V. Ponomarenko, A. O. Rubanenko, O. A. Rubanenko, F. E. Rustamova, V. A. Safronenko, E. I. Suchkova, A. I. Sycheva, D. R. Tagaeva, M. A. Trubnikova, T. P. Trunina, A. G. Frolov, V. V. Khatlamadzhiyan, Y. I. Khokhlova, A. I. Chernyavina, O. Y. Chizhova, M. A. Shambatov, T. V. Shnyukova, Y. V. Shchukin
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 4 (2024)
Aim. To investigate the prevalence and characteristics of polyvascular disease in the Eurasian region's population with one or more previously established locations of atherosclerotic arterial damage, and to evaluate the diagnostic importance of the
Externí odkaz:
https://doaj.org/article/f98daca5abd24d6487deebf4884d2cd2
Autor:
A. G. Arutyunov, M. M. Batyushin, G. P. Arutyunov, M. Yu. Lopatin, E. I. Tarlovskaya, A. I. Chesnikova, S. V. Nedogoda, A. S. Galyavich, D. S. Tokmin, T. I. Batluk, R. A. Bashkinov, E. D. Gordeychuk, E. S. Melnikov, E. V. Semenova, M. A. Trubnikova
Publikováno v:
Архивъ внутренней медицины, Vol 13, Iss 6, Pp 449-454 (2024)
Aim. To collect data on the patient phenotype at the highest risk of developing albuminuria, to assess the prevalence of albuminuria in the identified phenotypes, and to collect data on the characteristics, prescribed therapy, and comorbidities of pa
Externí odkaz:
https://doaj.org/article/7dbef691cdce44caa01013fd53faaaaf
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 4, Pp 55-62 (2024)
Relevance. Coenzyme Q10 is one of the main components that maintain the balance of the body's redox regulatory system. Although some studies have examined plasma concentrations of CoQ10 in various diseases, the distribution of ubiquinol and ubiquinon
Externí odkaz:
https://doaj.org/article/117a033a8fe64d439fac0ea5dc65f7a6
Autor:
G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, N. Yu. Grigorieva, I. V. Gubareva, U. K. Kamilova, Z. F. Kim, A. S. Kuznetsova, T. Yu. Kuznetsova, D. Yu. Ruzanov, A. V. Svarovskaya, E. А. Smirnova, A. B. Sugraliev, I. A. Frolova, G. T. Aimakhanova, T. I. Batluk, R. A. Bashkinov, I. V. Bikushova, E. D. Gordeychuk, E. Yu. Gubareva, D. S. Evdokimov, G. A. Zakirova, A. O. Loginova, E. S. Melnikov, N. B. Moiseenko, M. A. Trubnikova, S. Yu. Shcherbakov
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 3 (2024)
Aim. To analyze the lipid profile changes during the acute phase of coronavirus disease 2019 (COVID-19) and within 12 months after discharge from the hospital (post-Covid period) in comparison with the lipid profile of patients before COVID-19.Materi
Externí odkaz:
https://doaj.org/article/90ac8f2fff1947e2a4f881f447dfd356
Autor:
Moore, George W.
Publikováno v:
Arctic, 1998 Sep 01. 51(3), 288-289.
Externí odkaz:
https://www.jstor.org/stable/40512143
Publikováno v:
Неотложная медицинская помощь, Vol 12, Iss 2, Pp 217-223 (2023)
BACKGROUND The market of hypnotic and sedative drugs is being updated due to the high toxicity of barbiturates and the limitations of their use. Currently, safer drugs such as Z-drugs, Doxylamine, and some benzodiazepine derivatives are often prescri
Externí odkaz:
https://doaj.org/article/8607265db2804cde80467a575cfd9cff
Autor:
M. M. Batiushin, M. A. Trubnikova, E. I. Tarlovskaya, G. P. Arutyunov, T. I. Batluk, R. A. Bashkinov, E. S. Melnikov, A. G. Arutyunov
Publikováno v:
Архивъ внутренней медицины, Vol 13, Iss 2, Pp 116-128 (2023)
Objective. To study the course of the new coronavirus infection in patients with chronic kidney disease (CKD), to identify cases of acute kidney injury (AKI) in the setting of COVID-19 infection, and to access the impact of renal function on prognosi
Externí odkaz:
https://doaj.org/article/cc7633dd2c464347926ade4133aa41b3